Early trials for Moderna’s COVID-19 vaccine against South African variant begin, NIH says

The National Institutes of Health has officially begun early-stage trials of an investigational COVID-19 vaccine developed by Moderna to protect against a concerning coronavirus variant that was first identified in South Africa.